Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Lineage fate of ductular reactions in liver injury and carcinogenesis
Simone Jörs, Petia Jeliazkova, Marc Ringelhan, Julian Thalhammer, Stephanie Dürl, Jorge Ferrer, Maike Sander, Mathias Heikenwalder, Roland M. Schmid, Jens T. Siveke, Fabian Geisler
Simone Jörs, Petia Jeliazkova, Marc Ringelhan, Julian Thalhammer, Stephanie Dürl, Jorge Ferrer, Maike Sander, Mathias Heikenwalder, Roland M. Schmid, Jens T. Siveke, Fabian Geisler
View: Text | PDF
Research Article Hepatology

Lineage fate of ductular reactions in liver injury and carcinogenesis

  • Text
  • PDF
Abstract

Ductular reactions (DRs) are observed in virtually all forms of human liver disease; however, the histogenesis and function of DRs in liver injury are not entirely understood. It is widely believed that DRs contain bipotential liver progenitor cells (LPCs) that serve as an emergency cell pool to regenerate both cholangiocytes and hepatocytes and may eventually give rise to hepatocellular carcinoma (HCC). Here, we used a murine model that allows highly efficient and specific lineage labeling of the biliary compartment to analyze the histogenesis of DRs and their potential contribution to liver regeneration and carcinogenesis. In multiple experimental and genetic liver injury models, biliary cells were the predominant precursors of DRs but lacked substantial capacity to produce new hepatocytes, even when liver injuries were prolonged up to 12 months. Genetic modulation of NOTCH and/or WNT/β-catenin signaling within lineage-tagged DRs impaired DR expansion but failed to redirect DRs from biliary differentiation toward the hepatocyte lineage. Further, lineage-labeled DRs did not produce tumors in genetic and chemical HCC mouse models. In summary, we found no evidence in our system to support mouse biliary-derived DRs as an LPC pool to replenish hepatocytes in a quantitatively relevant way in injury or evidence that DRs give rise to HCCs.

Authors

Simone Jörs, Petia Jeliazkova, Marc Ringelhan, Julian Thalhammer, Stephanie Dürl, Jorge Ferrer, Maike Sander, Mathias Heikenwalder, Roland M. Schmid, Jens T. Siveke, Fabian Geisler

×

Figure 4

DDC-induced DRs do not escape their biliary fate after genetic ablation of NOTCH and/or activation of WNT/β-catenin signaling.

Options: View larger image (or click on image) Download as PowerPoint
DDC-induced DRs do not escape their biliary fate after genetic ablation ...
(A) For HNF1β compartment-specific genetic deletion of the NOTCH-adaptor protein RBP-Jκ and/or stable expression of the WNT effector β-catenin, R26Tom Rbpjfl/fl Hnf1b-CreER (n = 8), R26Tom CatnbΔex3 Hnf1b-CreER (n = 5), and R26Tom CatnbΔex3 Rbpjfl/fl Hnf1b-CreER (n = 4) animals were injected with tamoxifen (i.p., 100 μg/g BW at week 5) and subjected to 2 weeks of DDC diet (week 6–8). Equally treated R26Tom Hnf1b-CreER animals (n = 8) served as controls. Representative co-IF images for tdTom, tdTom/CK19, tdTom/Ki67, and tdTom/acetylated tubulin are shown that demonstrate reduced proliferative expansion and impaired biliary maturation of tdTom+ DRCs after both NOTCH inactivation and/or WNT/ β-catenin activation (arrows indicate tdTom+ DRCs that coexpress Ki67 or acetylated tubulin). In all models, DRCs failed to undergo lineage conversion to hepatocytes, as assessed by tdTom/HNF4α co-IF analysis. (B) Quantification of co-IF data (mean value ± SEM expressed in percentage; *P < 0.05, **P < 0.01, ***P < 0.001 [1-way ANOVA followed by Tukey’s post-test]). Scale bar: 100 μm (first column); 20 μm (second through fifth columns).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts